Clinical Trials Browser

Phase 2 × Pancreatic cancer, adult × Irinotecan × Clear all

NCT03977233 2026-01-13

Tumor Subtypes in Subjects on FOLFIRINOX With Non-Metastatic Pancreatic Cancer

Phase 2 Recruiting

Gastrointestinal

Pancreatic cancer, adult, Pancreatic Neoplasms